Artron Laboratories Inc. Announces Q1 2026 EPS of NT$0.28
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Artron Laboratories Inc. announced its Q1 2026 financial results, with EPS of NT$0.28, operating revenue of NT$88 million, and net income after tax of NT$17 million, reflecting steady business performance in the biotechnology and medical sector.